ARCHIVES

Waksal To Pay Back $800,000 In Profits From Stock Sales

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Biomarker Research “Piecemeal and Unorganized,” IOM Report Finds.

April 6, 2007

In Brief: Clinical Education Program to Be Phased Out; Ken Endicott Retires From Grupenhoff Firm

January 31, 1986

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974

CTCs Do Not Affect Survival, But Could Signal Metastases

December 30, 2011

Advisors Approve New Grant Programs In Breast Pre-Malignancy, Lung Inflammation

November 17, 2006

Appeals Court Lifts Injunction On Federal Funding for Stem Cell Research.

September 10, 2010